相关实验视频

Updated: Jul 27, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

在子宫内膜癌中升级治疗和分子诊断 - 推动子宫内膜保护的新工具?

Miriam Dellino¹, Marco Cerbone¹, Antonio Simone Laganà²

¹Obstetrics and Gynaecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.

International journal of molecular sciences

|June 10, 2023

概括

患有早期子宫内膜癌 (EC) 的年轻女性的生育能力保护需要个性化风险评估. 将分子数据与临床因素相结合,可以改善治疗量身定制和生育结果.

科学领域:

妇科瘤学妇科瘤学
生殖内分泌学生殖内分泌学
癌症基因组学癌症基因组学

背景情况:

在40岁以下的绝经前妇女中,早期子宫内膜癌 (EC) 发病率上升.
想要保持生育能力的愿望对标准的癌症治疗方案构成了挑战.
目前的指导方针经常建议进行激进的子宫切除术,影响生殖潜力.

研究的目的:

定义一个主要的风险评估框架,用于年轻EC患者的节育策略.
将分子分类与临床和传统风险因素相结合.
为了改善个性化治疗计划,希望保护生育能力的妇女.

主要方法:

审查关于子宫内膜癌管理和生育能力的现有文献和指导方针.
风险因素的分析,包括肌膜侵袭,FIGO分期,肥胖,多囊性卵巢综合征 (PCOS) 和糖尿病.
探索癌症基因组图谱 (TCGA) 分子分类在风险分层中的作用.

主要成果:

风险评估应包括肌肉膜侵袭,FIGO分期和TCGA分子亚型.
经典的危险因素,如肥胖,PCOS和糖尿病,显著影响生育结果.
多学科的团队方法提高了患者的满意度和生育结果.

结论:

个性化节育策略对于患有I期EC的绝经前妇女至关重要.
将TCGA分子分类与临床数据相结合,提供了一个强大的风险评估工具.
改善沟通和多学科的方法对于在妇科癌症患者成功的生育保护至关重要.

关键词:

这是子宫内膜癌的癌症.保护生育能力保护生育能力分子特征的分子表征.生殖结果的结果.

更多相关视频

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...